First Tracks Biotherapeutics, Inc. TRAX
45.43 USD -3.61 (-7.36%)
At closeNov 6, 2026, 7:35 AM EST
44.91 -0.52 -1.14%
Pre-market · Nov 6, 7:35 AM ET
44.47 Day range 49.00
14.72 52-week range 50.17
- YTD
- +139.11%
- 1 year
- +139.11%
Financial health
Altman Z-Score
56.26 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -4.0×
FY 2023 5y median -4.0× FY 2025
P/S 0.0×
FY 2023 5y median 0.0× FY 2025
P/B 2.3×
FY 2023 5y median 1.7× FY 2025
P/FCF -4.6×
FY 2023 5y median -5.2× FY 2025
EV/EBITDA -2.5×
FY 2023 5y median -3.1× FY 2025
EV/Sales 0.0×
FY 2023 5y median 0.0× FY 2025
FCF Yield -21.7%
FY 2023 5y median -19.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2023 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2023 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2023 5y median 0.0% FY 2025
ROE -57.8%
FY 2023 5y median -41.8% FY 2025
ROIC -59.4%
FY 2023 5y median -44.4% FY 2025
ROA -50.2%
FY 2023 5y median -37.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2023 FY 2025
Operating Income 1.2%
FY 2023 FY 2025
EPS (diluted) 0.0%
FY 2023 FY 2025
Free Cash Flow -13.4%
FY 2023 FY 2025
Financial Health
Current Ratio 10.2×
FY 2023 5y median 10.8× FY 2025
Quick Ratio 10.2×
FY 2023 5y median 10.8× FY 2025
Debt / Equity 0.0×
FY 2023 5y median 0.0× FY 2025
Net Debt / EBITDA 1.3×
FY 2023 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2023 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31